belzutifan
merck
['belzutifan', 'lite,spark-004']
belzutifan, a hif-2 inhibitor, for von hippel-lindau (vhl) disease associated neoplasms: 36 months of follow-up of the phase 2 litespark-004 study. presented by ramaprasad srinivasan, md, phd . #esmo22 written coverage &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology